File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Erratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7)
  • Basic View
  • Metadata View
  • XML View
TitleErratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7)
 
AuthorsMa, BBY2 3
Lui, VWY3
Poon, FF3
Wong, SCC3
To, KF2
Wong, E3
Chen, H1
Lo, KW3
Tao, Q3
Ng, MHL2
Cheng, SH2
Chan, ATC3
 
Issue Date2010
 
PublisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6997
 
CitationInvestigational New Drugs, 2010, v. 28 n. 3, p. 361 [How to Cite?]
DOI: http://dx.doi.org/10.1007/s10637-010-9397-3
 
ISSN0167-6997
2012 Impact Factor: 3.498
2012 SCImago Journal Rankings: 0.907
 
DOIhttp://dx.doi.org/10.1007/s10637-010-9397-3
 
DC FieldValue
dc.contributor.authorMa, BBY
 
dc.contributor.authorLui, VWY
 
dc.contributor.authorPoon, FF
 
dc.contributor.authorWong, SCC
 
dc.contributor.authorTo, KF
 
dc.contributor.authorWong, E
 
dc.contributor.authorChen, H
 
dc.contributor.authorLo, KW
 
dc.contributor.authorTao, Q
 
dc.contributor.authorNg, MHL
 
dc.contributor.authorCheng, SH
 
dc.contributor.authorChan, ATC
 
dc.date.accessioned2010-10-19T04:34:38Z
 
dc.date.available2010-10-19T04:34:38Z
 
dc.date.issued2010
 
dc.description.naturepublished_or_final_version
 
dc.description.otherSpringer Open Choice, 01 Dec 2010
 
dc.identifier.citationInvestigational New Drugs, 2010, v. 28 n. 3, p. 361 [How to Cite?]
DOI: http://dx.doi.org/10.1007/s10637-010-9397-3
 
dc.identifier.citeulike6804307
 
dc.identifier.doihttp://dx.doi.org/10.1007/s10637-010-9397-3
 
dc.identifier.eissn1573-0646
 
dc.identifier.epage361
 
dc.identifier.issn0167-6997
2012 Impact Factor: 3.498
2012 SCImago Journal Rankings: 0.907
 
dc.identifier.issue3
 
dc.identifier.scopuseid_2-s2.0-77952237521
 
dc.identifier.spage361
 
dc.identifier.urihttp://hdl.handle.net/10722/124033
 
dc.identifier.volume28
 
dc.languageEng
 
dc.publisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6997
 
dc.publisher.placeUnited States
 
dc.relation.ispartofInvestigational New Drugs
 
dc.rightsSpringer Science+Business Media, LLC
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.titleErratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7)
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Ma, BBY</contributor.author>
<contributor.author>Lui, VWY</contributor.author>
<contributor.author>Poon, FF</contributor.author>
<contributor.author>Wong, SCC</contributor.author>
<contributor.author>To, KF</contributor.author>
<contributor.author>Wong, E</contributor.author>
<contributor.author>Chen, H</contributor.author>
<contributor.author>Lo, KW</contributor.author>
<contributor.author>Tao, Q</contributor.author>
<contributor.author>Ng, MHL</contributor.author>
<contributor.author>Cheng, SH</contributor.author>
<contributor.author>Chan, ATC</contributor.author>
<date.accessioned>2010-10-19T04:34:38Z</date.accessioned>
<date.available>2010-10-19T04:34:38Z</date.available>
<date.issued>2010</date.issued>
<identifier.citation>Investigational New Drugs, 2010, v. 28 n. 3, p. 361</identifier.citation>
<identifier.issn>0167-6997</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/124033</identifier.uri>
<language>Eng</language>
<publisher>Springer New York LLC. The Journal&apos;s web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&amp;issn=0167-6997</publisher>
<relation.ispartof>Investigational New Drugs</relation.ispartof>
<rights>Springer Science+Business Media, LLC</rights>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<title>Erratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7)</title>
<type>Article</type>
<description.nature>published_or_final_version</description.nature>
<identifier.doi>10.1007/s10637-010-9397-3</identifier.doi>
<identifier.scopus>eid_2-s2.0-77952237521</identifier.scopus>
<identifier.volume>28</identifier.volume>
<identifier.issue>3</identifier.issue>
<identifier.spage>361</identifier.spage>
<identifier.epage>361</identifier.epage>
<identifier.eissn>1573-0646</identifier.eissn>
<publisher.place>United States</publisher.place>
<description.other>Springer Open Choice, 01 Dec 2010</description.other>
<identifier.citeulike>6804307</identifier.citeulike>
<bitstream.url>http://hub.hku.hk/bitstream/10722/124033/1/ft.pdf</bitstream.url>
</item>
Author Affiliations
  1. The University of Hong Kong
  2. Prince of Wales Hospital Hong Kong
  3. Chinese University of Hong Kong